Verified peer comparison
GRAIL vs Olema Pharmaceuticals Financial Comparison
Direct answer
GRAIL and Olema Pharmaceuticals are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free GRAIL email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- GRAIL Revenue
- 147,172,000 USD
- Olema Pharmaceuticals Revenue
- 0 USD
- GRAIL Operating income
- -534,163,000 USD
- Olema Pharmaceuticals Operating income
- -178,698,000 USD